Polymer Capital Management (Us) LLC Day One Biopharmaceuticals, Inc. Transaction History
Polymer Capital Management (Us) LLC
- $945 Billion
- Q3 2025
A detailed history of Polymer Capital Management (Us) LLC transactions in Day One Biopharmaceuticals, Inc. stock. As of the latest transaction made, Polymer Capital Management (Us) LLC holds 19,036 shares of DAWN stock, worth $167,516. This represents 0.01% of its overall portfolio holdings.
Number of Shares
19,036Holding current value
$167,516% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding DAWN
# of Institutions
179Shares Held
70.5MCall Options Held
42.8KPut Options Held
60.3K-
Atlas Venture Life Science Advisors, LLC6.43MShares$56.6 Million10.23% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.18MShares$54.4 Million0.0% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY4.71MShares$41.4 Million0.62% of portfolio
-
Black Rock Inc. New York, NY4.53MShares$39.9 Million0.0% of portfolio
-
Franklin Resources Inc San Mateo, CA3.48MShares$30.6 Million0.01% of portfolio
About Day One Biopharmaceuticals, Inc.
- Ticker DAWN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 73,461,104
- Market Cap $646M
- Description
- Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genetically defined cancers. Its lead product candidate is DAY101, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric pa...